CD20-TCB, a Novel T-Cell-Engaging Bispecific Antibody, Can Be Safely Combined with the Anti-PD-L1 Antibody Atezolizumab in Relapsed or Refractory B-Cell Non-Hodgkin LymphomaMartin Hutchings,Giuseppe Gritti,Anna Sureda,Maria Jose Terol,Martin J. S. Dyer,Gloria Iacoboni,William Townsend,Marina Bacac,Ann-Marie E. Broeske,Natalie Dimier,Cristiano Ferlini,Abiraj Keelara,Angelika Lahr,Katharina Lechner,Tom Moore,Peter N. Morcos,Anesh Panchal,Martin Weisser,Ciel De VriendtBlood（2019）引用 17|浏览45暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
